Paralytic diseases are spreading in Gaza as an Israeli blockade continues to prevent medicine and food from coming in. Since June, 85 suspected cases of Guillain-Barre syndrome (GBS) have been ...

Annexon Biosciences CEO Doug Love considers Guillain-Barré syndrome — also known as GBS — to be the “most unique disease” he’s worked on in 25 years in biotech because of its sudden onset. A rare ...

A technology company that advocates specialized booster systems is laying out a bold proposal for the FM band in the United States. GeoBroadcast Solutions says the FCC should allow broadcasters to ...

MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...

SHREVEPORT, La. - In 2011, Shane Sumlin's life changed overnight after being diagnosed with a rare neurological disorder called Guillain-Barre syndrome (GBS). It causes the body to attack its own ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Update concerning Guillain-Barré syndrome (GBS) following the administration of respiratory syncytial virus (RSV ...

Hansa Biopharma, “Hansa”, today announced positive high-level data from the 15-HMedIdeS-09 phase 2 trial that demonstrated imlifidase was safe and well tolerated when administered prior to standard of ...

MIAMI--(BUSINESS WIRE)--The Hackett Group, Inc. (NASDAQ: HCKT), a leading generative artificial intelligence (Gen AI) strategic consultancy and executive advisory firm, today released findings from ...

Researchers have identified handling of freshwater fish as the key risk factor in an outbreak in Hong Kong. Invasive Group B Streptococcus (GBS) infection caused by Sequence Type 283 (ST283) has also ...

Pune: A new study by ICMR-National Institute of Virology (NIV) has identified a mutated strain of norovirus — a hybrid form of the stomach bug better known for causing diarrhoea — as one of the key ...